soul trial oral semaglutide cardiovascular outcomes Outcomes, Safety, and Tolerability With Semaglutide: Insights for Managed Care The SOUL Study - by

Name: soul trial oral semaglutide cardiovascular outcomes Outcomes, Safety, and Tolerability With Semaglutide: Insights for Managed Care The SOUL Study - by
Brand: www.allread.ai
SKU: 94222304623
Price: 21.31 USD
Availability: InStock
Rating: 4.6723 (16 reviews)

SKU: 94222304623

4.7

USD21.31 USD46.31

Pay in 4 interest-free payments of $5.33 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

The SOUL Study by J Gamble, PhD RPh Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design ScienceDirect Oral Semaglutide's Impact on Cardiovascular Events in Type 2 Diabetes Patients with Cardiovascular and Kidney Disease: SOUL Trial Results PPTX Projected impact of oral semaglutide on cardiovascular outcomes over Download Scientific Diagram Oral Semaglutide and Cardiovascular Outcomes in High Risk Type 2 Diabetes New England Journal of Medicine ESC 365 Effects of oral semaglutide on heart failure outcomes in people with type 2 diabetes and atherosclerotic cardiovascular disease and or chronic kidney disease participating in SOUL trial

Store: www.allread.ai · Domain: www.allread.ai

Description

Our negative control outcome analyses (car accidents) showed no association between GLP-1RA initiation and new-onset AF/Aflutter, which is reassuring, though unmeasured confounders like variation on weight reduction and TSH may remain